Evidence map›Paper›PMID 42427979›Full record

ArticleFrontiers in veterinary science2026

Yueqi Yang, Jun Li, Jiayinaer Jikesanbayi, Kunlei Li, Bin Guo, Laizhen Liu, Meihe Hu, Songhan Liu, Jiahao Zhai, Xiaoying Wei and 3 more

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yueqi Yang *College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Jun Li *State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medicine Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Jiayinaer Jikesanbayi *College of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Kunlei LiCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Bin GuoState Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medicine Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Laizhen LiuCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Meihe HuYili Chuanning Biotechnology Co., Ltd., Yili, China.
Songhan LiuCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Jiahao ZhaiCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Xiaoying WeiCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Luheng XiaoCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Wenbao ZhangXin Jiang Key Laboratory of New Drug Researc and Development for Herbivorous Animals, Xinjiang Agricultural University, Urumqi, Xinjiang, China.
Shaohua ZhaiCollege of Veterinary Medicine, Xinjiang Agricultural University, Urumqi, Xinjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: The optimal extraction process of Results: The optimal extraction conditions (80% ethanol, solid-liquid ratio of 1:20, 60 °C for 30 min) yielded a flavonoid content of 10.72%. The crude flavonoid extract exerted a significant concentration-dependent inhibitory effect on protoscoleces, with an inhibition rate of 85.88% at 40 mg/mL for 24 h. The extract severely damaged protoscolex ultrastructure and upregulated Caspase-3 activity by 4.22-fold to induce protoscolex apoptosis. Biosafety evaluation confirmed that 10 mg/mL flavonoids had no obvious host cell toxicity, with a mouse oral LD₅₀ of 1.43 g/kg and no pathological damage in major organs. In vivo results showed that 20 mg/kg flavonoid treatment effectively reduced hepatic cyst numbers and promoted fibrotic repair in mice. Multi-omics analysis identified 50 flavonoid components and 25 differentially expressed proteins enriched in antiviral immune and RNA degradation pathways, and 16 flavonoids with high target-binding affinity were screened. Among them, myricetrin was the only active monomer, and 5 mg/mL myricetrin glycoside treatment significantly reduced liver cyst volume and achieved effective parasite clearance and tissue repair in vivo. Discussion: This study systematically demonstrates the prominent anti-echinococcosis activity and good biosafety of B. javanica flavonoids both in vitro and in vivo. The flavonoids kill E. granulosus protoscoleces by destroying parasite structure and activating apoptotic pathways, and alleviate liver lesions by promoting tissue fibrosis repair. Myricetrin is identified as the core active substance responsible for the anti-parasitic effect. These findings reveal the material basis and potential mechanism of B. javanica against echinococcosis, filling the gap of natural anti-echinococcosis drug research. This work provides a reliable experimental basis for the development of novel safe and efficient anti-echinococcosis natural drugs, and offers a new strategy for the clinical treatment of cystic echinococcosis.

Indexed as

B. javanica flavonoidsEchinococcus granulosusmetabolomicsmolecular dockingproteomics

Identifiers

PMID42427979
PMCPMC13347119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.